108 related articles for article (PubMed ID: 17064862)
21. Modeling of flux through silicone membranes from water.
Wasdo S; Juntunen J; Devarajan H; Murray T; Nickels D; Singh S; Shanks T; Ulmer K; Sloan KB
Eur J Pharm Sci; 2008 Aug; 34(4-5):321-32. PubMed ID: 18588972
[TBL] [Abstract][Full Text] [Related]
22. Topical delivery of 5-fluorouracil (5-Fu) by 3-alkylcarbonyl-5-Fu prodrugs.
Beall HD; Sloan KB
Int J Pharm; 2001 Apr; 217(1-2):127-37. PubMed ID: 11292549
[TBL] [Abstract][Full Text] [Related]
23. Effect of aminomethyl (N-Mannich base) derivatization on the ability of S6-acetyloxymethyl-6-mercaptopurine prodrug to deliver 6-mercaptopurine through hairless mouse skin.
Saab AN; Sloan KB; Beall HD; Villaneuva R
J Pharm Sci; 1990 Dec; 79(12):1099-104. PubMed ID: 2079657
[TBL] [Abstract][Full Text] [Related]
24. Topical delivery of 5-fluorouracil and 6-mercaptopurine by their alkylcarbonyloxymethyl prodrugs from water: vehicle effects on design of prodrugs.
Sloan KB; Wasdo S; Ezike-Mkparu U; Murray T; Nickels D; Singh S; Shanks T; Tovar J; Ulmer K; Waranis R
Pharm Res; 2003 Apr; 20(4):639-45. PubMed ID: 12739773
[TBL] [Abstract][Full Text] [Related]
25. Use of solubility parameters of drug and vehicle to predict flux through skin.
Sloan KB; Koch SA; Siver KG; Flowers FP
J Invest Dermatol; 1986 Aug; 87(2):244-52. PubMed ID: 3734472
[TBL] [Abstract][Full Text] [Related]
26. Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation.
Panchagnula R; Desu H; Jain A; Khandavilli S
Farmaco; 2005; 60(11-12):894-9. PubMed ID: 16126203
[TBL] [Abstract][Full Text] [Related]
27. Microemulsions as topical delivery vehicles for the anti-melanoma prodrug, temozolomide hexyl ester (TMZA-HE).
Suppasansatorn P; Nimmannit U; Conway BR; Du L; Wang Y
J Pharm Pharmacol; 2007 Jun; 59(6):787-94. PubMed ID: 17637171
[TBL] [Abstract][Full Text] [Related]
28. Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: S6-acyloxymethyl-6-mercaptopurine prodrugs.
Waranis RP; Sloan KB
J Pharm Sci; 1988 Mar; 77(3):210-5. PubMed ID: 3373424
[TBL] [Abstract][Full Text] [Related]
29. A correlation of flux through a silicone membrane with flux through hairless mouse skin and human skin in vitro.
Wasdo SC; Juntunen J; Devarajan H; Sloan KB
Int J Pharm; 2009 May; 373(1-2):62-7. PubMed ID: 19429289
[TBL] [Abstract][Full Text] [Related]
30. The effect of water solubility of solutes on their flux through human skin in vitro: a prodrug database integrated into the extended Flynn database.
Juntunen J; Majumdar S; Sloan KB
Int J Pharm; 2008 Mar; 351(1-2):92-103. PubMed ID: 18023303
[TBL] [Abstract][Full Text] [Related]
31. Diacyl glyceryl ester prodrugs for slow release in the skin: synthesis and in vitro degradation and absorption studies for naproxen derivatives.
Thorsteinsson T; Másson M; Loftsson T; Haraldsson GG; Stefánsson E
Pharmazie; 1999 Nov; 54(11):831-6. PubMed ID: 10603609
[TBL] [Abstract][Full Text] [Related]
32. Impact of ester promoieties on transdermal delivery of ketorolac.
Liu KS; Hsieh PW; Aljuffali IA; Lin YK; Chang SH; Wang JJ; Fang JY
J Pharm Sci; 2014 Mar; 103(3):974-86. PubMed ID: 24481782
[TBL] [Abstract][Full Text] [Related]
33. Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: bisacyloxymethyl-6-mercaptopurine prodrugs.
Waranis RP; Sloan KB
J Pharm Sci; 1987 Aug; 76(8):587-95. PubMed ID: 11002816
[TBL] [Abstract][Full Text] [Related]
34. Enhanced skin permeation of a new capsaicin derivative (DA-5018) from a binary vehicle system composed of isopropyl myristate and ethoxydiglycol.
Cha BJ; Lee ED; Kim WB; Chung SJ; Lee MH; Shim CK
Arch Pharm Res; 2001 Jun; 24(3):224-8. PubMed ID: 11440082
[TBL] [Abstract][Full Text] [Related]
35. Human skin permeation of branched-chain 3-0-alkyl ester and carbonate prodrugs of naltrexone.
Vaddi HK; Hamad MO; Chen J; Banks SL; Crooks PA; Stinchcomb AL
Pharm Res; 2005 May; 22(5):758-65. PubMed ID: 15906171
[TBL] [Abstract][Full Text] [Related]
36. Enhanced delivery of zidovudine through rat and human skin via ester prodrugs.
Seki T; Kawaguchi T; Juni K
Pharm Res; 1990 Sep; 7(9):948-52. PubMed ID: 2235895
[TBL] [Abstract][Full Text] [Related]
37. Hydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentration.
Chen H; Mou D; Du D; Chang X; Zhu D; Liu J; Xu H; Yang X
Int J Pharm; 2007 Aug; 341(1-2):78-84. PubMed ID: 17570625
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of transdermal apomorphine delivery with a diester prodrug strategy.
Liu KS; Sung KC; Al-Suwayeh SA; Ku MC; Chu CC; Wang JJ; Fang JY
Eur J Pharm Biopharm; 2011 Aug; 78(3):422-31. PubMed ID: 21315820
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of the water-isopropyl myristate system.
Abraham MH; Acree WE
Int J Pharm; 2005 Apr; 294(1-2):121-8. PubMed ID: 15814236
[TBL] [Abstract][Full Text] [Related]
40. Permeation of buprenorphine and its 3-alkyl-ester prodrugs through human skin.
Stinchcomb AL; Paliwal A; Dua R; Imoto H; Woodard RW; Flynn GL
Pharm Res; 1996 Oct; 13(10):1519-23. PubMed ID: 8899844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
